From ABC.go.com…
The Food and Drug Administration on Thursday authorized Merck’s COVID-19 pill for certain adults.
The authorization for molnupiravir is limited to adults over 18 who have a high risk of severe illness and “for whom alternative FDA-authorized treatment options are not accessible or medically appropriate,” the FDA said in a press release Thursday. It’s not recommended for use in pregnant people.
This is the second COVID-19 treatment in pill form after Pfizer’s pill, Paxlovid, was authorized Wednesday. Paxlovid is authorized for a slightly larger pool of people — anyone over 12 and at high risk of severe illness.
